These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33431202)

  • 1. Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.
    Frey KA
    Semin Nucl Med; 2021 May; 51(3):275-285. PubMed ID: 33431202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.
    Villemagne VL; Okamura N
    Curr Opin Neurobiol; 2016 Feb; 36():43-51. PubMed ID: 26397020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
    Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
    Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.
    Palleis C; Sauerbeck J; Beyer L; Harris S; Schmitt J; Morenas-Rodriguez E; Finze A; Nitschmann A; Ruch-Rubinstein F; Eckenweber F; Biechele G; Blume T; Shi Y; Weidinger E; Prix C; Bötzel K; Danek A; Rauchmann BS; Stöcklein S; Lindner S; Unterrainer M; Albert NL; Wetzel C; Rupprecht R; Rominger A; Bartenstein P; Herms J; Perneczky R; Haass C; Levin J; Höglinger GU; Brendel M
    Mov Disord; 2021 Apr; 36(4):883-894. PubMed ID: 33245166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature.
    Rini J; Asken B; Geier E; Rankin K; Kramer J; Boxer A; Miller B; Yokoyama J; Spina S
    Neurocase; 2021 Apr; 27(2):120-128. PubMed ID: 33754963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
    Dickson DW; Kouri N; Murray ME; Josephs KA
    J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Roemer SN; Brendel M; Gnörich J; Malpetti M; Zaganjori M; Quattrone A; Gross M; Steward A; Dewenter A; Wagner F; Dehsarvi A; Ferschmann C; Wall S; Palleis C; Rauchmann BS; Katzdobler S; Jäck A; Stockbauer A; Fietzek UM; Bernhardt AM; Weidinger E; Zwergal A; Stöcklein S; Perneczky R; Barthel H; Sabri O; Levin J; Höglinger GU; Franzmeier N
    Brain; 2024 Jul; 147(7):2428-2439. PubMed ID: 38842726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.
    Stamelou M; Respondek G; Giagkou N; Whitwell JL; Kovacs GG; Höglinger GU
    Nat Rev Neurol; 2021 Oct; 17(10):601-620. PubMed ID: 34426686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
    Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
    Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.